Beta-blockers as fourth-line therapy for hypertension: stay the course.
Bangalore
S
S
Brigham and Women's Hospital, Boston, MA, USA.
Messerli
F H
FH
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000139:chemically induced; D050171:Dyslipidemias / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents